CLINICAL_TRIALS
trial_result
· 2022-08-24
Clinical Trial Update: Efficacy of Cerebrolysin Treatment as an add-on Therapy to Mechanical Thrombectomy in Acute Ischemic Stroke. [Phase 3]
Summary
Phase 3 trial evaluating Cerebrolysin as add-on therapy to mechanical thrombectomy in acute ischemic stroke.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Military Institute od Medicine National Research Institute | Conditions: Stroke, Ischemic, Stroke, Acute | Phase 3 | Status: UNKNOWN